These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21715978)

  • 1. The power of chemotherapeutic engineering: arresting cell cycle and suppressing senescence to protect from mitotic inhibitors.
    Blagosklonny MV
    Cell Cycle; 2011 Jul; 10(14):2295-8. PubMed ID: 21715978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin, proliferation and geroconversion to senescence.
    Blagosklonny MV
    Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53: The pivot between cell cycle arrest and senescence.
    Santoro R; Blandino G
    Cell Cycle; 2010 Nov; 9(21):4262-3. PubMed ID: 21057199
    [No Abstract]   [Full Text] [Related]  

  • 4. MEK drives cyclin D1 hyperelevation during geroconversion.
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Cell Death Differ; 2013 Sep; 20(9):1241-9. PubMed ID: 23852369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
    Leontieva OV; Demidenko ZN; Gudkov AV; Blagosklonny MV
    PLoS One; 2011; 6(10):e26126. PubMed ID: 22022534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.
    Leontieva OV; Blagosklonny MV
    Cell Cycle; 2013 Sep; 12(18):3063-9. PubMed ID: 23974099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin decelerates cellular senescence.
    Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
    Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of senescence by adenosine suppressing the growth of lung cancer cells.
    Yang D; Song J; Wu L; Ma Y; Song C; Dovat S; Nishizaki T; Liu J
    Biochem Biophys Res Commun; 2013 Oct; 440(1):62-7. PubMed ID: 24051088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells.
    Gu JJ; Kaufman GP; Mavis C; Czuczman MS; Hernandez-Ilizaliturri FJ
    Oncotarget; 2017 Feb; 8(8):12741-12753. PubMed ID: 28055975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
    Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y
    Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.
    Blagosklonny MV
    Aging (Albany NY); 2012 Mar; 4(3):159-65. PubMed ID: 22394614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical suppression of cellular senescence by p53.
    Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
    Osman AA; Monroe MM; Ortega Alves MV; Patel AA; Katsonis P; Fitzgerald AL; Neskey DM; Frederick MJ; Woo SH; Caulin C; Hsu TK; McDonald TO; Kimmel M; Meyn RE; Lichtarge O; Myers JN
    Mol Cancer Ther; 2015 Feb; 14(2):608-19. PubMed ID: 25504633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic catastrophe and p53-dependent senescence induction in T-cell malignancies exposed to nonlethal dosage of GL-V9.
    Li H; Hu P; Wang Z; Wang H; Yu X; Wang X; Qing Y; Zhu M; Xu J; Li Z; Guo Q; Hui H
    Arch Toxicol; 2020 Jan; 94(1):305-323. PubMed ID: 31760435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
    Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
    Mirzayans R; Andrais B; Kumar P; Murray D
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy.
    Hsu CH; Altschuler SJ; Wu LF
    Cell; 2019 Jul; 178(2):361-373.e12. PubMed ID: 31204100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak p53 permits senescence during cell cycle arrest.
    Leontieva OV; Gudkov AV; Blagosklonny MV
    Cell Cycle; 2010 Nov; 9(21):4323-7. PubMed ID: 21051933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.